FDA: HIV drug combo might cause a serious heart problem

10/21/2010 | Reuters

The FDA is revising the labels of Abbott Laboratories' Norvir and Genentech's Invirase to include a warning about the risk of abnormal heart rhythm when the HIV drugs are taken together. Separately, European regulators reviewed data on the risk and advised patients to take a low-dose Invirase for a week initially, as a precautionary measure.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC